- $2.42bn
- $3.51bn
- $2.84bn
Annual income statement for HNI, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,362 | 2,184 | 2,434 | 2,526 | 2,839 |
| Cost of Revenue | |||||
| Gross Profit | 844 | 765 | 948 | 1,038 | 1,179 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,207 | 2,099 | 2,344 | 2,320 | 2,713 |
| Operating Profit | 155 | 85.4 | 90.3 | 207 | 126 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 146 | 78.3 | 64.8 | 179 | 90.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 124 | 59.8 | 49.2 | 140 | 54.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 124 | 59.8 | 49.2 | 140 | 54.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 124 | 59.8 | 49.2 | 140 | 54.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.24 | 1.63 | 2.52 | 3.06 | 2.52 |
| Dividends per Share |